Document is current
Any future updates will be listed below
-
Authors
Gabriel, Rodney A.
Curran, Brian P.
Said, Engy T.
Tsuda, Paige S.
Bongbong, Dale N.
Deconde, Adam S.
Yan, Carol H.
Ingrande, Jerry
-
Funding
Funding for this research was provided by:
Merck
- License Information
-
More Information
Article History
Received: 19 June 2025
Accepted: 29 March 2026
First Online: 31 March 2026
Declarations
:
: Supported in part by a research grant from Investigator-Initiated Studies Program of Merck Sharp & Dohme LLC, a subsidiary of Merck & Co., Inc., Rahway, NJ, USA. The opinions expressed in this paper are those of the authors and do not necessarily represent those of Merck Sharp & Dohme LLC, a subsidiary of Merck & Co., Inc., Rahway, NJ, USA. RG and ES’s institution has received funding and/or product for research purposes from Epimed, Infutronix, SPR Therapeutics, Merck & Co, Inc, and Precision Genetics. Dr Gabriel is a consultant for Avanos. JI’s institution received funding by Merck & Co, Inc.
